-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Sonnet BioTherapeutics Holdings, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2014 to Q4 2024.
- Sonnet BioTherapeutics Holdings, Inc. Earnings Per Share, Basic for the quarter ending December 31, 2024 was -1.56 USD/shares, a 36.6% increase year-over-year.
- Sonnet BioTherapeutics Holdings, Inc. Earnings Per Share, Basic for the twelve months ending December 31, 2024 was -10.5 USD/shares, a 92% increase year-over-year.
- Sonnet BioTherapeutics Holdings, Inc. annual Earnings Per Share, Basic for 2024 was -11.4 USD/shares, a 92.2% increase from 2023.
- Sonnet BioTherapeutics Holdings, Inc. annual Earnings Per Share, Basic for 2023 was -145 USD/shares, a 3.58% increase from 2022.
- Sonnet BioTherapeutics Holdings, Inc. annual Earnings Per Share, Basic for 2022 was -151 USD/shares, a 956% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)